Linking central sensitization to multisystemic manifestations in hypermobile Ehlers-Danlos syndrome
By
Ana Paula Montemayor Zarazúa
César Vidal Elizondo Solis
Camila Ayala García
Diego Jesús Pacheco Estrella
Octavio Ilizaliturri Guerra
Ana Cecilia Arana Guajardo
Emma Purón Gonzalez
Karina Silva Luna
Luis Iván Lozano Plata
Mario Ramon García Pompermayer
Mario Alberto Garza Elizondo
June 30, 2026
Clinical Scorecard: Examining the Relationship Between Central Sensitization and Diverse Symptoms in Hypermobile Ehlers-Danlos Syndrome
At a Glance
Category Detail
Condition Hypermobile Ehlers-Danlos Syndrome (hEDS) and Hypermobility Spectrum Disorders (HSD) Key Mechanisms Central Sensitization (CS) as a unifying mechanism for chronic pain and multisystemic symptoms Target Population Adults diagnosed with hEDS/HSD Care Setting Specialized joint hypermobility clinic
Key Highlights
Central Sensitization Inventory (CSI) scores correlate with multisystemic symptoms in hEDS/HSD patients. Independent predictors of central sensitization include fatigue, pain, and cardiac dysautonomia. Centrally sensitized patients are predominantly younger and female. Guideline-Based Recommendations
Diagnosis
Use the Central Sensitization Inventory (CSI) for assessing central sensitization. Management
Implement multidisciplinary strategies to address the sensitized state in hEDS/HSD patients. Monitoring & Follow-up
Regularly evaluate symptom burden using the SPIDER questionnaire alongside CSI. Risks
Increased sensitivity to stimuli and multisystemic symptoms may impair quality of life. Patient & Prescribing Data
Adults with clinical diagnosis of hEDS/HSD
Management should focus on addressing the triad of fatigue, pain, and cardiac dysautonomia.
Clinical Best Practices
Conduct standardized clinical evaluations for joint hypermobility. Utilize validated screening tools for comprehensive symptom assessment. Related Resources & Content
